Miller Howard Investments Inc Catalyst Pharmaceuticals, Inc. Transaction History

Miller Howard Investments Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 26, 2024	BUY	$11.78 - $17.29 $4,653 - $6,829	395 Added 1.23%	32,439 $545,000
Q3 2023 Oct 18, 2023	SELL	$11.69 - $15.02 $678 - $871	-58 Reduced 0.18%	32,044 $374,000
Q2 2023 Jul 21, 2023	BUY	$11.5 - $18.08 $2,369 - $3,724	206 Added 0.65%	32,102 $431,000
Q1 2023 May 03, 2023	BUY	$14.34 - $21.05 $4,775 - $7,009	333 Added 1.06%	31,896 $528,000
Q4 2022 Feb 02, 2023	BUY	$12.25 - $19.5 $49 - $78	4 Added 0.01%	31,563 $587,000
Q3 2022 Oct 27, 2022	BUY	$7.06 - $15.52 $522 - $1,148	74 Added 0.24%	31,559 $405,000
Q2 2022 Jul 26, 2022	BUY	$6.23 - $8.57 $196,151 - $269,826	31,485 New	31,485 $221,000

326

94.6M

19.1K

51.1K

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.12B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

Get notified when there are updates to the investment portfolio of Miller Howard Investments Inc , based on Form 13F filings with the SEC.

Stay updated on Miller Howard Investments Inc with notifications on news.